Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0002007919-25-000012·Inhibrx Biosciences, Inc.
Schedule 13D ownership disclosure
Inhibrx Biosciences Inc
Common Stock, par value $0.0001 per share · CUSIP: 45720N103
Event date: 2024-09-12
- Filing-level shares
- 925,413.00
- Percent of class
- 6.4%
- Mark LappeReported CIK 0001366074
Shares: 925,413.00 · Class: 6.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002007919-25-000012
- Form type
- SCHEDULE 13D/A
- Filer
- Inhibrx Biosciences, Inc.
- CIK
- CIK 2007919
- Filed
- Feb 26, 2025
- Reporting period
- Sep 12, 2024
- Description
- Schedule 13D beneficial ownership